The fluoroquinoline compound exerts anti-erythroleukemic effects by dual-targeting GLUT1 and the PI3K/AKT signaling pathway

Abstract Erythroleukemia is a rare hematological malignancy in clinical practice, and currently, there are no effective treatment options other than stem cell transplantation. The study found that the fluoroquinoline compound FKL-137 can significantly inhibit the proliferation of erythroleukemia cel...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sha Cheng, Weijia Zhao, Jia Yu, Xueling Meng, Bixue Xu, Ningning Zan, Baofei Sun, Heng Luo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Nature Portfolio 2026-03-01
Serie:	Scientific Reports
Soggetti:	Fluoroquinoline Erythroleukemia GLUT1 PI3K/AKT Glucose metabolism Glycolysis
Accesso online:	https://doi.org/10.1038/s41598-026-45597-9
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!